The ongoing COVID-19 mass testing and vaccination campaigns are the result of unprecedented financial investments, rapid research and development, collaborative science, and innovation in delivery systems. It would be a shame to not leverage these systems for other priorities in global health.
No takes yet. Share an insight, caveat, or question.
Rühwald et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: